Pulmonary arterial hypertension in patients with congenital heart disease: Current issues and health care situation;Pulmonalarterielle Hypertonie bei angeborenen Herzfehlern: Problemstellung und Versorgungslage

Deutsche Medizinische Wochenschrift

Volumn 138, Issue 23, 2013, Pages 1247-1252

  Kaemmerer, H ^a   Gorenflo, M ^b   Hoeper, M ^c   Huscher, D ^d   Ewert, P ^a   Pittrow, D ^e  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

congenital heart disease; health care; left right shunt; pulmonary arterial hypertension; quality of life; survival

Indexed keywords

CONGENITAL HEART DISEASE; HEALTH CARE; HUMAN; PULMONARY HYPERTENSION; REVIEW;

ADULT; ANTICOAGULANTS; ANTIHYPERTENSIVE AGENTS; CHILD; COMBINED MODALITY THERAPY; COOPERATIVE BEHAVIOR; CROSS-SECTIONAL STUDIES; EISENMENGER COMPLEX; EXERCISE TEST; FEMALE; HEART DEFECTS, CONGENITAL; HEART SEPTAL DEFECTS, VENTRICULAR; HEMODYNAMICS; HUMANS; HYPERTENSION, PULMONARY; INTERDISCIPLINARY COMMUNICATION; MALE; PHOSPHODIESTERASE 5 INHIBITORS; PROGNOSIS; PROSTAGLANDINS I; PULMONARY ARTERY; QUALITY OF LIFE; RECEPTORS, ENDOTHELIN; REGISTRIES; RISK FACTORS;

EID: 84878461553     PISSN: 00120472     EISSN: 14394413     Source Type: Journal    
DOI: 10.1055/s-0033-1343189     Document Type: Review

References (30)

1. Kaemmerer H., Niwa K., Hess J. Das Eisenmenger-Syndrom - vom Symptom zu Diagnose und Therapie. Bremen UNI-MED-Verlag: 2011
2. Barst R. J., Gibbs J. SR, Ghofrani H. A. et al. Updated Evidence-Based Treatment Algorithm in Pulmonary Arterial Hypertension. J Am Coll Cardiol: 2009; 54 78 84
3. Barst R. J., McGoon M., Torbicki A. et al. Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol: 2004; 43 40S 47S (Pubitemid 38759716)
4. Baumgartner H., Bonhoeffer P., De Groot N. M. et al. ESC Guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J: 2010; 31 2915 2957
5. Beghetti M., Galie N. Eisenmenger syndrome a clinical perspective in a new therapeutic era of pulmonary arterial hypertension. J Am Coll Cardiol: 2009; 53 733 740
6. Ciliberti P., Giardini A. Impact of oral chronic administration of sildenafil in children and young adults after the Fontan operation. Future Cardiol: 2011; 7 609 612
7. Condliffe R., Kiely D. G., Coghlan J. G. et al. Survival in pulmonary hypertension registries: the importance of incident cases. Chest: 2011; 139 1547 1548; author reply 1548-1549
8. Diller G. P., Gatzoulis M. A. Pulmonary vascular disease in adults with congenital heart disease. Circulation: 2007; 115 1039 1050 (Pubitemid 46328298)
9. Dimopoulos K., Giannakoulas G., Wort S. J. et al. Pulmonary arterial hypertension in adults with congenital heart disease: distinct differences from other causes of pulmonary arterial hypertension and management implications. Curr Opin Cardiol: 2008; 23 545 554
10. Dimopoulos K., Inuzuka R., Goletto S. et al. Improved survival among patients with Eisenmenger syndrome receiving advanced therapy for pulmonary arterial hypertension. Circulation: 2010; 121 20 25
11. Duffels M. G., Engelfriet P. M., Berger R. M. et al. Pulmonary arterial hypertension in congenital heart disease: an epidemiologic perspective from a Dutch registry. Int J Cardiol: 2007; 120 198 204 (Pubitemid 47042253)
12. Engelfriet P., Boersma E., Oechslin E. et al. The spectrum of adult congenital heart disease in Europe: morbidity and mortality in a 5 year follow-up period. The Euro Heart Survey on adult congenital heart disease. Eur Heart J: 2005; 26 2325 2333 (Pubitemid 41541399)
13. Engelfriet P. M., Duffels M. G., Moller T. et al. Pulmonary arterial hypertension in adults born with a heart septal defect: the Euro Heart Survey on adult congenital heart disease. Heart: 2007; 93 682 687 (Pubitemid 46808265)
14. Galie N., Beghetti M., Gatzoulis M. A. et al. Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study. Circulation: 2006; 114 48 54 (Pubitemid 44305274)
15. Galie N., Manes A., Negro L. et al. A meta-analysis of randomized controlled trials in pulmonary arterial hypertension. Eur Heart J: 2009; 30 394 403
16. Gatzoulis M. A., Beghetti M., Galie N. et al. Longer-term bosentan therapy improves functional capacity in Eisenmenger syndrome: results of the BREATHE-5 open-label extension study. Int J Cardiol: 2008; 127 27 32 (Pubitemid 351707527)
17. Ghofrani H. A., Distler O., Gerhardt F. et al. Treatment of pulmonary arterial hypertension (PAH): updated Recommendations of the Cologne Consensus Conference 2011. Int J Cardiol: 2011; 154 01 20 33
18. Grabitz R. G., Kaemmerer H., Mohr F. W. Angeborene Herzfehler im Erwachsenenalter. Internist: 2013; 54 20 27
19. Hoeper M. M., Huscher D., Ghofrani H. A. et al. Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: Results from the COMPERA registry. Int J Cardiol: 2012; Nov 16. doi: pii: S0167-5273(12)01401-5. 10.1016/j.ijcard.2012.10.026 [Epub ahead of print]
20. Kaemmerer H., Bauer U., de Haan F. et al. Recommendations for improving the quality of the interdisciplinary medical care of grown-ups with congenital heart disease (GUCH). Int J Cardiol: 2011; 150 59 64
21. Kaemmerer H., Hess J. [Congenital heart disease. Transition from adolescence to adulthood]. Der Internist: 2009; 50 1221 1222, 1224-1227
22. Lowe B. S., Therrien J., Ionescu-Ittu R. et al. Diagnosis of pulmonary hypertension in the congenital heart disease adult population impact on outcomes. J Am Coll Cardiol: 2011; 58 538 546
23. McLaughlin V. V., Archer S. L., Badesch D. B. et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc. 2009; 53 1573 1619
24. Mulder B. J. Changing demographics of pulmonary arterial hypertension in congenital heart disease. Eur Resp Rev: 2010; 19 308 313
25. Pittrow D., Ghofrani H. A., Opitz C. F. et al. Internationales, prospektives Register zur Erfassung der Initial- und Dauertherapie von Patienten mit pulmonaler Hypertonie (CompERA-XL). Dtsch Med Wochenschr: 2009; 134 05 173 175
26. Schmaltz A. A., Bauer U., Baumgartner H. et al. [Medical guideline for the treatment of adults with congenital heart abnormalities of the German-Austrian-Swiss Cardiology Specialty Society]. Clin Res Cardiol: 2008; 97 194 214 (Pubitemid 351712816)
27. Schoetzau A., van Santen F., Sauer U. et al. Kardiovaskuläre Fehlbildungen in Bayern 1984-1991. Z Kardiol: 1997; 86 496 504
28. Simonneau G., Robbins I. M., Beghetti M. et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol: 2009; 54 43 54
29. Wood P. The Eisenmenger syndrome or pulmonary hypertension with reversed central shunt. Brit Med J: 1958; 2 755 762
30. Wren C., O'Sullivan J. J. Survival with congenital heart disease and need for follow up in adult life. Heart: 2001; 85 438 443 (Pubitemid 32973534)